In a filing, Johnson & Johnson revealed its VP Corporate Controller Decker Robert J unloaded Company’s shares for reported $1.16 million on Feb 25 ’25. In the deal valued at $165.88 per share,6,999 shares were sold. As a result of this transaction, Decker Robert J now holds 21,001 shares worth roughly $3.2 million.
Then, Decker Robert J bought 6,999 shares, generating $1,161,010 in total proceeds.
Before that, Schmid Timothy sold 403 shares. Johnson & Johnson shares valued at $62,928 were divested by the EVP, WW Chair, MedTech at a price of $156.15 per share. As a result of the transaction, Schmid Timothy now holds 15,098 shares, worth roughly $2.3 million.
Leerink Partners downgraded its Johnson & Johnson [JNJ] rating to a Market perform from a an Outperform in a research note published recently. Wolfe Research began covering JNJ with “an Outperform” recommendation on November 15, 2024. Daiwa Securities revised its rating on July 23, 2024. It rated JNJ as “a Neutral” which previously was an “an Outperform”.
Price Performance Review of JNJ
On Tuesday, Johnson & Johnson [NYSE:JNJ] saw its stock fall -1.83% to $152.38. Over the last five days, the stock has lost -2.60%. Johnson & Johnson shares have risen nearly 5.37% since the year began. Nevertheless, the stocks have risen 4.76% over the past one year. While a 52-week high of $169.99 was reached on 03/04/25, a 52-week low of $140.68 was recorded on 01/10/25.
Levels Of Support And Resistance For JNJ Stock
The 24-hour chart illustrates a support level at 151.23, which if violated will result in even more drops to 150.08. On the upside, there is a resistance level at 154.40. A further resistance level may holdings at 156.43.
